Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma.
Richardson PG, Durie BG, Rosiñol L, Mateos MV, Dispenzieri A, Moreau P, Kumar S, Raje N, Munshi N, Laubach JP, O'Gorman P, O'Donnell E, Voorhees P, Facon T, Bladé J, Lonial S, Perrot A, Anderson KC.
Richardson PG, et al. Among authors: kumar s.
Haematologica. 2023 Nov 1;108(11):2894-2912. doi: 10.3324/haematol.2022.282624.
Haematologica. 2023.
PMID: 37608773
Free PMC article.